Commentary
Clinical Pharmacology & Therapeutics (2007) 82, 370–373. doi:10.1038/sj.clpt.6100352
Targeting Cell Death
D J Hausenloy1 and L Scorrano2
- 1The Hatter Cardiovascular Institute, University College London Hospital, London, UK
- 2Dulbecco-Telethon Institute, Venetian Institute of Molecular Medicine, Padova, Italy
Correspondence: L Scorrano, (lscorrano@dti.telethon.it)
